Literature DB >> 35608794

Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.

JunJie Fu1, Jun Liu1, XuePing Wen1, Guirong Zhang1, Ji Cai1, Zongwei Qiao2, Zheming An2, Jia Zheng2, Li Li3.   

Abstract

Saccharomyces boulardii (S. boulardii) is a probiotic and is widely used to improve the nutritional and functional value of food. This study aimed to compare the probiotic properties of S. boulardii and Saccharomyces cerevisiae. A series of in vitro probiotic experiments was performed, including simulated gastrointestinal digestion, bile salt tolerance, hydrophobicity, self-aggregation, and antioxidant and antibacterial properties. Self-aggregation and hydrophobic properties of S. boulardii were relatively poor, but they showed high tolerance, antioxidant properties, and broad antibacterial properties. In addition, non-targeted metabolomics was used to comprehensively analyze the active metabolites of S. boulardii and the metabolic differences between S. boulardii and S. cerevisiae were compared. Saccharomyces boulardii produced many bioactive metabolites, which generally showed antioxidant, antibacterial, antitumor, anti-inflammatory, and other properties. In contrast to S. cerevisiae, S. boulardii produced phenyllactic acid and 2-hydroxyisocaproic acid. There were also significant differences in their metabolic pathways. These results may be of great significance in the medical and food industries and provide a basis for understanding the metabolism of S. boulardii. It also shows that metabolomics is an effective and novel method for screening microbial functional metabolites and identifying functional differences between similar microorganisms.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioactive metabolites; Metabolites; Metabolomics; Probiotic properties; Saccharomyces boulardii

Year:  2022        PMID: 35608794     DOI: 10.1007/s12602-022-09953-1

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  44 in total

1.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

2.  Bioconversion of isoflavone glycosides to aglycones, mineral bioavailability and vitamin B complex in fermented soymilk by probiotic bacteria and yeast.

Authors:  C R Rekha; G Vijayalakshmi
Journal:  J Appl Microbiol       Date:  2010-08-19       Impact factor: 3.772

3.  Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains.

Authors:  C Hennequin; A Thierry; G F Richard; G Lecointre; H V Nguyen; C Gaillardin; B Dujon
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats.

Authors:  J P Buts; N De Keyser; S Marandi; D Hermans; E M Sokal; Y H Chae; L Lambotte; H Chanteux; P M Tulkens
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation.

Authors:  Jean-Paul Buts; Nadine Dekeyser; Catherine Stilmant; Emilie Delem; Francoise Smets; Etienne Sokal
Journal:  Pediatr Res       Date:  2006-05-11       Impact factor: 3.756

6.  Review article: yeast as probiotics -- Saccharomyces boulardii.

Authors:  D Czerucka; T Piche; P Rampal
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

7.  Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.

Authors:  A C Rodrigues; R M Nardi; E A Bambirra; E C Vieira; J R Nicoli
Journal:  J Appl Bacteriol       Date:  1996-09

8.  Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

Authors:  C Pothoulakis; C P Kelly; M A Joshi; N Gao; C J O'Keane; I Castagliuolo; J T Lamont
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

Review 9.  Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.

Authors:  M A Lazo-Vélez; S O Serna-Saldívar; M F Rosales-Medina; M Tinoco-Alvear; M Briones-García
Journal:  J Appl Microbiol       Date:  2018-08-16       Impact factor: 3.772

10.  Rice bran fermented with saccharomyces boulardii generates novel metabolite profiles with bioactivity.

Authors:  Elizabeth P Ryan; Adam L Heuberger; Tiffany L Weir; Brittany Barnett; Corey D Broeckling; Jessica E Prenni
Journal:  J Agric Food Chem       Date:  2011-02-09       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.